Founded Year
2021Stage
Seed VC | AliveAbout Huixin Yigu
Huixin Yigu is a biopharmaceutical enterprise focusing on the field of cell therapy for neurological diseases. It uses reprogramming technology and a non-integrated system to directly induce neural stem cells (iNSCs) from human peripheral blood mononuclear cells or fibroblasts. The company was founded in 2021 and is based in Beijing, China.
Missing: Huixin Yigu's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Huixin Yigu's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Huixin Yigu Frequently Asked Questions (FAQ)
When was Huixin Yigu founded?
Huixin Yigu was founded in 2021.
Where is Huixin Yigu's headquarters?
Huixin Yigu's headquarters is located at Room 101, Floor 2-12, No. 6, District 1, No. 8, Beijing.
What is Huixin Yigu's latest funding round?
Huixin Yigu's latest funding round is Seed VC.
Who are the investors of Huixin Yigu?
Investors of Huixin Yigu include Green Pine Capital Partners.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.